Dr Yannick BARDIE, MSc, PhD

Positioning

A Doctor of Management Sciences and health engineer by training, I have for more than thirty years pursued action research at the intersection of pharmaceutical safety, clinical information systems, risk governance in high-reliability organisations (HRO) and, more recently, the cognitive dynamics linked to artificial intelligence. This dual affiliation, academic (lecturer-researcher, author) and professional (consultant, trainer, company director), underpins a practitioner-academic positioning in the sense of the AACSB framework.

My current work focuses on cognitive governmentality, emotions as the architectures of opinion democracy, and the symbolic neo-institutions of the 21st century. I pass it on through teaching in management schools, executive education, keynotes, boot camps, crisis simulations and a mentoring practice with executives, elected officials and young professionals.

Motto: “Not simply to understand change, but to structure it.”

Current roles

Teaching

• Since 2017, EMLV, Pôle Universitaire Léonard de Vinci (Paris-La Défense). Bachelor, Master and Executive MBA teaching: International Business Strategy (Work-Study Master MScD, in French and English), Digital Economy (Bachelor BTM), Business Ethics, Big Data Ecosystem and Big Data & Data Analytics, Information Systems Management, Quality Advanced Project Management, Quality Management, Global Supply Chain, Persuading & Selling, Negotiation, Research Seminar, Cognitive Architecture, Discovering the Company, Pedagogy of AI, IT Security and Ethics (GDPR regulation). Lecturer and professional tutor on the Executive MBA (DVHE, CSR & Business Impact). Tutoring of work-study students in companies (including Safran, Euronext, France TV, LCL, Sopra Steria).
• Since 2018, ESA, École Supérieure d'Assurances (Paris). Biomedical risk insurance; group insurance.
• Since 2000, Université de Montpellier. Faculty of Science: creation of innovative businesses (L1, since 2011). Faculty of Pharmacy: health engineering, supervision of 12 pharmacy practice theses. IAE: communication and negotiation.

Management, institutions and associations

• Since 2011, founder and president, Intelligence in Life. Think-and-do tank and strategic consulting and applied research firm: health intelligence, cognitive transformation of organisations, executive training. Management of a catalogue of 57 training courses and of the Intelligence in Life publishing series (Sauramps Médical).
• Director of the Observatoire Sciences & Société, Institut Sapiens. Analyses and publications on the relationships between science, society and public policy.
• Special adviser, Institut de Refondation Publique (IRP). Influence briefs and analyses on cognitive governmentality and opinion democracy, in collaboration with Régis Passerieux.
• Since 2020, president of ANAT (Association Nationale des ARC et TEC, the national association of CRAs and CTAs). Representation and structuring of the clinical research associate profession; organisation of the national meetings (RNAT) and of symposia in partnership with DVHE.
• Since 2015, member of the Comité de Protection des Personnes Sud Méditerranée IV (research ethics committee). Qualified person in biomedical research ethics; deputy vice-president.
• President, Quantic Enterprises. Strategy, digitalisation, internationalisation.
• Director of three Spanish companies: Intelligence in Life S.L. (consulting, executive training, research, publishing), Enjoy Cataluña S.L. (venues, hospitality and art de vivre, including the Maison Suntuosidad), Quantic Philosophy S.L. (technology, software publishing, R&D, incubation).
• Co-founder, FlightDesk (SAS being incorporated, with Paul Laisné): an AI agent cockpit for hospitality, construction and mobility.
• Aurevelis Group holding project (being structured, 2026), an umbrella entity intended to bring these companies and their brands together.
• Since 2013, founder and scientific director, VOUTE SAS / C-LEST Clinical. Digital and payment services for clinical trials; design of modular ERPs dedicated to clinical research.
• Since 2006, member of Rotary International.
• Columnist for The European Scientist and contributor to La Tribune.
• GSDC speaker (Global Skill Development Council): keynotes and ISO certification boot camps.

Professional experience

Clinical research and the healthcare industry (since 1994)

• Since 2013, VOUTE SAS. Founder, inventor of the C-LEST Clinical solution (patient expense reimbursement and financial management of clinical trials) and scientific director: team supervision, contracts with investigators and institutions, submissions to authorities and ethics committees, training of CRAs and CTAs.
• 2013-2017, consulting and monitoring assignments: clinical development programme for an ophthalmological device for a German manufacturer (2016-2017); on-site monitoring of a phase IIIb study in neurology (2014-2017); sponsor representative in France for a US oncology biotech, phase III (2014-2015), for an Israeli manufacturer of a urological device, CE marking study (2013-2015), and for a feasibility study in hepatology (2013); review of CE marking files, classes I and II, drafting of MEDDEV documents (2013-2014).
• Since 2011, Intelligence in Life. Academic and industrial development in clinical research and information systems geared towards Risk Based Monitoring; clinical expertise, legal representation and “for cause” monitoring.
• 1999-2010, Recherche & Développement Clinique (RD Clinique). Creation (1999) then management: legal representation in the EU for foreign clients, management of study budgets and financial contracts, payments to sites, investigators and service providers, training of CRAs and CTAs. Assignments as an independent CRA: cardiology (hypertension, angina, stroke), gynaecology (phase IIb), neurology and transplantation (phase III), endocrinology, pulmonology and gastroenterology (phase IV), veterinary studies.
• 2000-2010, artificial pancreas. Involvement in the world's first implantation of an artificial pancreas at the Montpellier University Hospital (Pr Renard, Lapeyronie hospital) and follow-up of the study for seven years, including an ANSM inspection; in 2008, R&D Clinique became sponsor of an artificial pancreas trial.
• 2008 R&D Clinique became a member of AFCROs (the French CRO federation).
• 2007 R&D Clinique became the French franchise of QED Clinical Systems.
• 1998-1999, Farma Versus. Clinical research associate, Southern region.
• 1997-1998, Groupe MAPI S.A. Clinical research associate, Southern region.
• 1996, Pasteur Mérieux Sérums et Vaccins (Lyon). European clinical research associate (Switzerland, Belgium, Italy, the Netherlands, Germany, United Kingdom).
• 1994-1995, Sanofi Recherche (Montpellier). International clinical research associate.

Therapeutic areas: oncology, cardiology, neurology, vaccinology, ophthalmology (medical device), urology, hepatology, dermatology, transplantation, gastroenterology, endocrinology, antibiotic therapy.

Consulting, information systems and entrepreneurship

• Design of modular ERPs for clinical research, pharmacovigilance, contract management and quality management (SIMAX, ClinOps, MEDIBASE, COLIBASE, Clin'FORCE); platform for the financial and operational management of clinical trials geared towards Risk Based Monitoring (C-LEST Clinical).
• Legal representation in the European Union for foreign sponsors; regulatory expertise (ANSM, LNE-G.Med, notified bodies).
• Strategic health consulting for international partners: structuring of local clinical research (ICH-GCP), AI-assisted pharmacovigilance, pharmaceutical industrial development, medical devices and cosmetics, talent training.

Industry partners (selection)

Sanofi, Sanofi Pasteur, Aventis Pasteur, AstraZeneca, SmithKline Beecham, Pierre Fabre Médicaments, Biocodex, The Medicines Company, Medtronic-MiniMed, Medical Research Group (MRG, United States), MDCI (Medical Device Consultants International), Kendle, PRA International, ICON, Parexel, Outcome, CTI, EORTC, Amersham Health, Cangene (Canada), PhotoCure (Norway), NAMSA, ClinSearch, MAPI, Aster Institute (phase I).

Academic and institutional partners (selection)

Université de Montpellier (Faculty of Pharmacy, Faculty of Medicine, MRM-SI), EM Normandie, EMLV / Pôle Léonard de Vinci, ESILV, IIM, SKEMA Business School, HEIP, INSEEC, Sup Santé, ESA, ESISMP Casablanca, Institut Sapiens, Institut de Refondation Publique, Centre d'essais en vol de Brétigny-sur-Orge (Aerospace Medicine Laboratory), health clusters, development agencies, diplomatic institutions and chambers of commerce.

Teaching (full history)

• 2017 to date EMLV / Pôle Léonard de Vinci: see Current roles. Institut Léonard de Vinci: courses for clinical research associates, pharmaceutical safety and Risk Based Monitoring.
• 2018 to date ESA: biomedical risk insurance; group insurance.
• 2020 OMNES Education, HEIP (political science): neo-institutional theories; professional coaching and soft skills; innovation management in the BITD (defence industrial and technological base).
• 2016-2017 SKEMA Business School (visiting lecturer): information systems, socio-materiality and security; BPMN techniques.
• 2015 IAE Montpellier: communication and negotiation.
• 2012 ESISMP Casablanca (Morocco), in partnership with Université de Montpellier I: health engineering and project management.
• 2011 to date Université des Sciences de Montpellier (L1): creation of innovative businesses.
• 2010-2018 INSEEC Sup Santé Paris: training of clinical research associates; history and regulation of clinical trials; pharmacovigilance; Risk Based Monitoring.
• Since 2010 Université de Montpellier: associate lecturer (Faculty of Pharmacy and Institut d'Administration des Entreprises); health marketing course in Master II, Faculty of Medicine.
• 2008-2010 Université de Nîmes: creation of innovative businesses.
• 2018 CESEGH, Montpellier: speaker on the DU Sustainable Development Management in Health (DU-MDDS), as a clinical research expert.
• 2007 EORTC: training, in English, of project managers in workload planning and management.
• LNE-G.Med (notified body): speaker for the training of ANSM staff.
• 2000-2015 Faculty of Pharmacy of Montpellier: part-time lecturer, member of the Advisory Board of Health Engineering and of the professional jury.
• EM Normandie: pedagogy and teaching (dates to be confirmed).

Conferences, keynotes and presentations

• 31/01/2026 GSDC Certified Learning “The ISO Leadership Reset: Building a Resilient, Secure, and Accountable Enterprise”: talk “Designing an Effective Risk Management Framework Using ISO 31000” (certificate of recognition as a speaker, Global Skill Development Council).
• 23/03/2026 lecture at the Sorbonne: AI, emotional intelligence and metacognition.
• January 2025 CES Las Vegas: talk on uses of AI in healthcare.
• 06/10/2023 Senate (Paris): presentation of the findings on the standardisation of non-pharmacological interventions (NPIS meeting, INSERM mission).
• May 2022 ANAT symposium: the functions of the sponsor CRA in clinical trials.
• AFCROs, Clinical Research Day: workshop “Manager les essais cliniques avec le Risk Based Monitoring” (Managing clinical trials with Risk Based Monitoring).
• 2018 AIM Congress, Montréal: “Le management du risque en pharmacovigilance, point de vue de la théorie néo-institutionnelle” (Risk management in pharmacovigilance: a neo-institutional theory perspective).
• 2016 ELMED Congress, Montpellier: processing of weak signals from information systems in clinical trials.
• 2016 Doctoral consortium: GCP-ICH traceability and a health surveillance information system in clinical trials.
• Merlin, A., Ravel, P., Fargette, M., Satoto, T. B. T., Kister, G., Bardie, Y., et al. Progress report of the Modeling group for Chikungunya Dynamic in Asian regions (MoDyCA).
• 2013 Joint International Tropical Medicine Meeting (Bangkok) and Dengue Symposium, Gadjah Mada University (Indonesia): “New concepts in dengue vector control” (Frutos, Merlin, Bardie et al.).
• 2010 and 2008 ERP Software Solutions Show, CNIT Paris-La Défense: choosing, implementing and integrating an ERP in SMEs; mobile and cloud solutions.
• 2009 Sup de Co Montpellier, MTO 2009: the network as an organisational model for the emergence of innovative therapies.
• 2009 CHU Saint-Éloi, Montpellier, seminar on therapeutic trials: Directive 2001/20/EC, an original means of promotion.
• Since 2006 Rotary International: talks including “Essais thérapeutiques, mode d'emploi” (Therapeutic trials: a user's guide) (history, regulation and methodology of clinical trials).
• National CRA-CTA meeting and ceremony for the 20th anniversary of the IUP Ingénierie de la Santé: evolution of European regulation of therapeutic trials.
• Organisation of the national meetings of CRAs and CTAs (RNAT) on behalf of ANAT.

Media

Appearances as a clinical research expert following the accident in the phase I trial of BIA 10-2474 (Biotrial, Rennes, 2016):

• France 24, 9 pm news, 15/01/2016.
• i-Télé, 1 pm news, 15/01/2016.
• El País, interview, 15/01/2016.
• Sud Radio, interview, 15/01/2016; “L'invité pour comprendre”, 11/10/2016, after publication of the investigation report.
• Journal du Dimanche, 18/01/2016: “Accident d'essai clinique à Rennes : le mystère du BIA 10-2474”.
• Le Nouvel Observateur, 21/01/2016: article and interview, “L'essai clinique est un exercice très dangereux”.
• M6, 7 pm news, January 2016.
• Politico Europe, March 2016, after the IGAS report.

Publications

Books

• Bardie, Y. (2026). Du Glaive au Scalpel. Guerre et médecine, une histoire croisée. Éditions de la République (publication October 2026; collaboration with Bruno Fuligni).
• Bardie, Y. (2022). Vers un management agile de la sûreté pharmaceutique. Une approche néo-institutionnelle et polycentrique de l'écosystème de sécurité sanitaire. Preface by Thérèse Libourel. Paris: L'Harmattan.
• Bardie, Y. (2013). Essais cliniques. Du patient à l'objet de science : renaissance éthique. Preface by Pr Claude Huriet. Montpellier: Sauramps Médical.
• Léon, K., & Bardie, Y. La technologie Blockchain appliquée à la santé. Les données patients en question. Montpellier: Sauramps Médical / Intelligence in Life.
• Bardie, Y., & Mantione, F. (forthcoming). Les Entreprises de Soi. L'Homme est une entreprise comme les autres.
• Bardie, Y. (in preparation). La gouvernementalité cognitive : pouvoir, savoir et architectures de la décision contemporaine.

Forthcoming books (as of 06/07/2025)

• Une philosophie de la santé (Gadamer, Illich, WHO, salutogenesis, AI and the medicine of the future): being finalised.
• Science et pouvoir au XXIe siècle (knowledge, Foucault, geopolitics of intelligence): in progress.
• La fin de vie à l'ère de l'IA (decision-making, autonomy, responsibility, bioethics): in proofreading.
• Les Entreprises de Soi, tome 2 : taxonomie et gouvernance: in preparation.
• Éducation spectaculaire (immersive methodology, embodied learning, boot camps): being written.

Thesis

• Bardie, Y. (2022). Vers un management agile de la sûreté pharmaceutique, une approche néo-institutionnelle et polycentrique de l'écosystème de sécurité sanitaire [Doctoral thesis, Université de Montpellier, MRM-SI, supervised by Thérèse Libourel]. theses.fr.

Book chapters and edited volumes

• Calmé, I., & Polge, M. (Eds.) (2023). Pratiquer l'entrepreneuriat en 17 cas d'entreprises : Doctolib, La Ruche, Café Joyeux. Paris: Dunod (FNEGE-labelled book). Contribution.
• Bardie, Y., & Libourel, T. (2018). Information Systems for Supporting Strategic Decisions and Alerts in Pharmacovigilance. In F. Sèdes (Ed.), How Information Systems Can Help in Alarm/Alert Detection (pp. 133-164). Elsevier.

Peer-reviewed journal articles

• Ninot, G., Bardie, Y., Bernard, P. L., Franco, G., Lambert-Cordillac, K., Stubbe, L., ... & Nogues, M. (2024). NPIS, la société savante internationale dédiée à la recherche sur les interventions non médicamenteuses (NPIS, the international learned society dedicated to research on non-pharmacological interventions). Kinésithérapie, la Revue, 24(270), 3-8.
• Bardie, Y. (2019). Essais cliniques. Du patient à l'objet de science. Revue Hegel.
• Bardie, Y. (2018). La réglementation dédiée à l'évaluation des interventions non médicamenteuses (INM). Hegel, 8(1), 28-34.
• Fargette, M., Frutos, R., Merlin, A., Ravel, P., Satoto, T. B. T., Andayani, E., ... Bardie, Y., ... & Libourel, T. (2015). Observatoire Scientifique en Appui à la GEstion de la Santé sur un territoire (OSAGE-S). Dynamiques environnementales, (36), 58-81.

Conference proceedings and working papers

• Bardie, Y., Le Rouge, T., & Fallery, B. (2018). Le management du risque en pharmacovigilance, point de vue de la théorie néo-institutionnelle (hal-01889818). AIM Congress, Montréal.
• Bardie, Y. (2016). SI pour aide à la décision stratégique et alerte en pharmacovigilance. Informatique des Organisations et Systèmes d'Information et de Décision (INFORSID).
• Bardie, Y. (2016). Nouvelles approches de la sûreté pharmaceutique par le traitement des signaux faibles des SI dans le domaine des essais cliniques. Actes du congrès ELMED, Montpellier.
• Bardie, Y. (2016). Could the principle of traceability promulgated by GCP-ICH (the matrix) be the support of an information system (IS) of sanitary watch in clinical trials? Doctoral consortium.
• Bardie, Y. (2014). Essais cliniques : vers une renaissance éthique ? Working paper, ResearchGate.

Press and columns

• Bardie, Y. (06/04/2026). Dérive consumériste : quand le marketing start-up s'empare du business de la santé. La Tribune.
• Columns in The European Scientist, including “ONG vs lobbies : comment naissent les institutions” and “Du PANG à l'entreprise distribuée : vers une veille collaborative post-militaire ?”.

Practical guides (Amazon KDP)

• CAGE Framework : mesurer les distances pour décider à l'international (cultural, administrative, geographic and economic distances; Netflix case and Excel model).
• Les 3 A de la stratégie internationale : Adaptation, Agrégation, Arbitrage. Le trilemme de Ghemawat pour décideurs.
• TOC en 60 minutes. Théorie des contraintes de Goldratt.

Series editorship

• Intelligence in Life series, Sauramps Médical publishers. First title: Dupressoir, M., Les systèmes d'information et la santé. L'intégrité en question.

Research and areas of expertise

• Pharmaceutical safety and pharmacovigilance; detection of weak signals in clinical information systems.
• Neo-institutional approaches (DiMaggio and Powell, Lawrence and Suddaby) applied to healthcare ecosystems; polycentric governance (Elinor Ostrom) of local health regulation arenas.
• Non-pharmacological interventions: scientific and regulatory framing, in connection with NPIS.
• Clinical information systems, Risk Based Monitoring, GCP-ICH traceability and design of business ERPs.
• Risk governance in high-reliability organisations (ISO 31000, Nancy Leveson's STAMP model).
• Artificial intelligence, metacognition and cognitive sentinels; algorithmic governance (ISO/IEC 24029-1).
• Cognitive warfare, cognitive governmentality, emotions and opinion democracy; symbolic neo-institutions (IRP and Institut Sapiens work).
• Intertwined history of war and medicine.

Intelligence in Life training catalogue

57 modules in five formats (executive boot camps, thematic workshops, mentoring, LearnEx self-learning pathways, doctoral support), aimed at management committees (CODIR) and executive committees (COMEX), managers, entrepreneurs, students and doctoral candidates. A pedagogy of “spectacular education”: staging of knowledge, cognitive anchoring and active engagement.

• AI, algorithmic governance and digital transformation: AI and emotional intelligence (metacognition, cognitive sentinels); AI Bias Assessment & Governance, ISO/IEC 24029-1 (with GSDC); Artificial Intelligence, Fundamentals and Strategic Applications; Digital Business Transition, Pivot or Perish, The Digital Transition Manager, Startup vs Corporate and Transformation of Government Agencies boot camps, Executive Boot Camp at Sea (MSC Yacht Club).
• Risk governance and HRO: ISO 31000 in high-reliability organisations; Care is a humanism applied to clinical research; Daring to Trust.
• Leadership, communication and negotiation: Aristotelian rhetoric; the art of negotiation; Communication Champion; DISC; team cohesion through theatre.
• Management and change management: managerial posture, manager-coach, feedback, performance management, recruitment, time management, recognition at work, generation clash, ecology of organisational transformation.
• Strategy, business models and entrepreneurship: Lean Canvas; LearnEx pathways (digital business model, transformation governance, digital economy, Transition Navigator).
• Cognitive performance and well-being: speed reading and memory, method of loci, stress management, emotional intelligence, Stationary Traveller boot camp.
• University pedagogy and doctoral support: flipped classroom; The Adventure of the Doctoral Thesis; professional integration.
• Other: Suntuosidad module (service culture and hospitality rituals); personal network; financial education; transition boot camps on the Costa Brava, in the Seychelles and in exceptional settings (Vortex).

Education and degrees

• 2022 Doctorate in Management Sciences (Doctorat en Sciences de Gestion), Information Systems applied to pharmaceutical safety (2015-2022), Université de Montpellier, MRM-SI.
• 2015 Master 2 Opérations cliniques et gestion de projets (Clinical Operations and Project Management), Biology and Health specialisation, Faculty of Pharmacy of Montpellier.
• 1994 Ingénieur Santé (Health Engineer), IUP Ingénierie de la Santé (1991-1994), Faculty of Pharmacy, Université de Montpellier I.
• 1990-1991 DEUG B1, first year of biology, Université de Perpignan.
• 1989-1990 PCEM1, first year of medicine, Montpellier.
• 1989 Baccalauréat D (natural and life sciences), with honours.

Languages

French (mother tongue); English (fluent, teaching and publishing); Spanish (fluent); Italian (basic); Catalan (basic).

Technical skills

• Modelling: BPMN (yEd, Bizagi), UML, MS Project, XMind.
• Clinical research: EDC, CTMS, BBN Clintrial; business ERPs.
• Pedagogical integration of generative AI (ChatGPT, Claude, code and diagram generation).
• Theory of Constraints, Critical Chain Project Management.
• Linux Ubuntu environments, Microsoft Office suite.

Awards and certifications

• Certificate of Achievement, Global Skill Development Council (31/01/2026), in recognition of the contribution as a speaker to “The ISO Leadership Reset”.

Interests

• Civil aviation private pilot (since 1997); aerobatics, introductory level (2010).
• Running: Paris marathon 2003 (3 h 26); Yvelines marathon 2003 (3 h 08); sprint triathlon (2003, 2012).
• Writing (essays and fiction); amateur theatre, adaptation of “Les Pas perdus” by Denise Bonal.

References

Available on request, in particular from the Université de Montpellier (MRM-SI, Faculty of Pharmacy), EMLV, the CPP Sud Méditerranée IV, the Institut Sapiens and the Institut de Refondation Publique.